PROCTER & GAMBLE HEALTH | MOREPEN LABS | PROCTER & GAMBLE HEALTH/ MOREPEN LABS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 34.2 | 101.1% | View Chart |
P/BV | x | 10.6 | 3.5 | 304.9% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH MOREPEN LABS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
MOREPEN LABS Mar-23 |
PROCTER & GAMBLE HEALTH/ MOREPEN LABS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 55 | 9,791.2% | |
Low | Rs | 3,883 | 24 | 16,418.6% | |
Sales per share (Unadj.) | Rs | 740.7 | 27.7 | 2,671.1% | |
Earnings per share (Unadj.) | Rs | 138.2 | 0.8 | 18,270.1% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 1.3 | 11,908.0% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | 14.7 | 3,039.0% | |
Shares outstanding (eoy) | m | 16.60 | 511.17 | 3.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 1.4 | 441.3% | |
Avg P/E ratio | x | 33.5 | 51.8 | 64.5% | |
P/CF ratio (eoy) | x | 29.8 | 30.1 | 99.0% | |
Price / Book Value ratio | x | 10.3 | 2.7 | 387.9% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 20,051 | 382.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 1,547 | 133.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 14,175 | 86.7% | |
Other income | Rs m | 184 | 61 | 299.9% | |
Total revenues | Rs m | 12,480 | 14,237 | 87.7% | |
Gross profit | Rs m | 3,247 | 795 | 408.2% | |
Depreciation | Rs m | 281 | 279 | 100.6% | |
Interest | Rs m | 8 | 20 | 38.9% | |
Profit before tax | Rs m | 3,142 | 558 | 563.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 171 | 496.1% | |
Profit after tax | Rs m | 2,295 | 387 | 593.3% | |
Gross profit margin | % | 26.4 | 5.6 | 470.6% | |
Effective tax rate | % | 27.0 | 30.6 | 88.0% | |
Net profit margin | % | 18.7 | 2.7 | 684.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 7,562 | 154.9% | |
Current liabilities | Rs m | 6,791 | 3,212 | 211.4% | |
Net working cap to sales | % | 40.0 | 30.7 | 130.4% | |
Current ratio | x | 1.7 | 2.4 | 73.3% | |
Inventory Days | Days | 263 | 18 | 1,450.7% | |
Debtors Days | Days | 343 | 678 | 50.7% | |
Net fixed assets | Rs m | 10,617 | 3,543 | 299.6% | |
Share capital | Rs m | 166 | 1,022 | 16.2% | |
"Free" reserves | Rs m | 7,265 | 6,507 | 111.6% | |
Net worth | Rs m | 7,431 | 7,529 | 98.7% | |
Long term debt | Rs m | 0 | 9 | 0.0% | |
Total assets | Rs m | 22,330 | 11,105 | 201.1% | |
Interest coverage | x | 409.1 | 29.1 | 1,403.5% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 0.6 | 1.3 | 43.1% | |
Return on assets | % | 10.3 | 3.7 | 281.6% | |
Return on equity | % | 30.9 | 5.1 | 601.2% | |
Return on capital | % | 42.4 | 7.7 | 553.5% | |
Exports to sales | % | 0 | 39.9 | 0.0% | |
Imports to sales | % | 13.1 | 30.5 | 42.8% | |
Exports (fob) | Rs m | NA | 5,657 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 4,324 | 37.1% | |
Fx inflow | Rs m | 1,465 | 5,657 | 25.9% | |
Fx outflow | Rs m | 1,605 | 4,444 | 36.1% | |
Net fx | Rs m | -140 | 1,213 | -11.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | -912 | -258.9% | |
From Investments | Rs m | -215 | -465 | 46.2% | |
From Financial Activity | Rs m | -985 | 1,435 | -68.6% | |
Net Cashflow | Rs m | 1,160 | 59 | 1,979.0% |
Indian Promoters | % | 0.0 | 38.2 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 4.0 | 498.0% | |
FIIs | % | 6.2 | 1.9 | 337.3% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 61.8 | 78.0% | |
Shareholders | 56,778 | 336,019 | 16.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | MOREPEN LABS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 1.76% | 0.45% |
1-Month | -1.15% | 21.24% | 2.55% |
1-Year | 0.73% | 86.88% | 56.14% |
3-Year CAGR | -8.76% | -0.01% | 15.22% |
5-Year CAGR | 4.97% | 24.56% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the MOREPEN LABS share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of MOREPEN LABS the stake stands at 38.2%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of MOREPEN LABS.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
MOREPEN LABS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of MOREPEN LABS.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.